Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol and probenecid for hypertension prevention in obese adolescents
NCT00288158Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Sep 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of allopurinol, probenecid in prehypertension, hyperuricemia, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Sep 2008; status: completed.
02
Drugs
allopurinolprobenecid
03
Conditions
prehypertensionhyperuricemia
Beyond the preview
Go deeper on NCT00288158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288158.